The Intelligence from The Economist cover image

Irish ayes? A new Brexit deal

The Intelligence from The Economist

00:00

Psychedelics in Mental Health Treatment

This chapter examines the rising interest in psychedelics as viable treatments for mental health issues, contrasting their medical research with the cannabis industry. It discusses safety concerns, recent FDA approvals for psilocybin trials, and the potential for new technologies to enhance psychedelic therapies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app